GlassScriptPhysician profile
Susan Schaill
NPI 1578376596
$4,206.95
in general payments reported to CMS, 2019-2025
18 companies · $4,207 in 2025
The $4,207 reported for 2025 was more than what 98% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $4,207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,206.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $849.80 | 2025 | |
| Neurocrine Biosciences, INC. | $520.53 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $391.03 | 2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Alkermes, INC. | $388.29 | 2025 | Aristada, Lybalvi, Vivitrol |
| E.R. Squibb & Sons, L.L.C. | $311.49 | 2025 | Cobenfy |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $309.05 | 2025 | Caplyta |
| Supernus Pharmaceuticals, INC. | $279.90 | 2025 | Qelbree |
| Teva Pharmaceuticals USA, INC. | $270.78 | 2025 | Austedo Xr, Uzedy |
| Indivior INC. | $256.05 | 2025 | Sublocade |
| Vanda Pharmaceuticals INC. | $174.51 | 2025 | Fanapt |
| Janssen Pharmaceuticals, INC | $149.41 | 2025 | Spravato, Invega |
| Lundbeck LLC | $137.68 | 2025 | Rexulti |
| Lilly USA, LLC | $34.83 | 2025 | Zepbound |
| Tms Neurohealth Centers INC. | $33.82 | 2025 | Tms Neurohealth Centers INC. |
| Takeda Pharmaceuticals U.S.A., INC. | $29.70 | 2025 | Trintellix |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neuronetics, INC. | $24.24 | 2025 | Neurostar Tms Therapy System |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $23.95 | 2025 | Rexulti |
| Almatica Pharma LLC | $21.89 | 2025 | Loreev Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Schaill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.